Healthcare - Biotechnology - NASDAQ - US
$ 0.4035
-1.59 %
$ 68 M
Market Cap
3.1
P/E
Price Target
Average
808.72%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
31.18%
Net Income
Estimate
48.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
X4 Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for XFOR of $3.67 , with forecasts ranging from a low of $3 to a high of $5 .
XFOR Lowest Price Target
Wall Street Target
3 USD
643.49%
XFOR Average Price Target
Wall Street Target
3.67 USD
808.72%
XFOR Highest Price Target
Wall Street Target
5 USD
1139.16%
REVENUE FORECAST
Revenue Forecast Chart XFOR
EBIT FORECAST
EBIT Forecast Chart XFOR
NET INCOME FORECAST
Net Income Chart XFOR